Autolus (UK) has secured over €51M in a recent series B round, led by the biggest Biotech VC in Europe – and a new player in life science investment.
I tried figuring out what exactly Autolus is doing. It doesn’t disclose so much of its scientific strategy, but whatever the strategy is, it seems to have investors convinced. This Biopharma has now raised around €51.2M (£40M) in a series B round.
Other investor is Perceptive Bioscience, its first investment since the opening of the fund in London last February. It is led by some key figures in the industry,